Name | Antisauvagine-30 |
---|---|
Synonyms |
H-D-Phe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2
D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2 H-D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THE-ILE-OH M.W. 3650.29 C161H274N48O46S Antisauvagine 30 |
Description | Antisauvagine-30 (aSvg-30) is a potent, competitive and selective CRF2 receptor antagonist with Kd values of 1.4 nM and 153.6 nM for mouse CRF2β and rat CRF1 receptors, respectively[1]. |
---|---|
Related Catalog | |
Target |
Kd: 1.4 nM (mouse CRF2β) ;Kd: 153.6 nM (rat CRF1)[1] |
References |
Molecular Formula | C161H274N48O46S |
---|---|
Molecular Weight | 3651.24000 |
Exact Mass | 3649.01000 |
PSA | 1611.26000 |
LogP | 8.45320 |
Safety Phrases | 22-24/25 |
---|---|
WGK Germany | 3 |